Abciximab is a drug used to reduce the risk of a heart attack during coronary surgery.
30min
Patients can typically begin ambulation within 6 to 24 hours after a ReoPro (abciximab) infusion, depending on their clinical status and the specific indications for the treatment. It is essential to monitor the patient for any signs of bleeding or complications before allowing ambulation. Always follow the healthcare provider's recommendations and protocols for individual patient care.
More correctly it is called antiplatelet aggregation drugs (also called antithrombotic drugs) that include aspirin, clopidogrel, abciximab (monoclonal antibodies) and GPII/ IIIA receptors antagonists etc. Each drug has its own way and mechanism of action. It depends upon chemical structure of drug and site of action. Aspirin blocks aggregation by inhibiting cycloxygenase that produce thromboxane A2 that causes platelet aggregation. Clopidogrel acts as antagonist to P2Y2 receptors present on platelets required for their aggregation. You can check for further details. Umar Mujahid Pharm.D u.mujahid@yahoo.com